s-allylcysteine has been researched along with Multiple-Sclerosis* in 1 studies
1 other study(ies) available for s-allylcysteine and Multiple-Sclerosis
Article | Year |
---|---|
Dose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitis.
Garlic is a component of the Mediterranean diet. S-allyl cysteine (SAC), the most common organosulphur present in garlic, possesses neuroprotective properties. This investigation was performed to evaluate the dose-dependent protective action of SAC on oxidative damage, inflammation and gut microbiota alterations biomarkers. Experimental autoimmune encephalomyelitis (EAE) as a model of multiple sclerosis (MS) was induced by the myelin oligodendrocyte glycoprotein (MOG), whose effects were quantified by examining the changes in: clinical score, lipid peroxidation products, carbonylated proteins, glutathione system, tumor necrosis factor alpha (TNFα), and lipopolysaccharide membrane bacteria (LPS). Our results reveal that MOG induces paralysis, oxidative damage and increases in LPS binding protein (LBP) and LPS levels. In this work, two doses of SAC were compared with two dose of N-acetyl cysteine (NAC). SAC was more effective than NAC and it prevented the harmful effects induced by MOG more effectively at the dose of 50mg/kg than that of 18mg/kg. Surprisingly, NAC increases LBP levels while SAC had not such negative effect. In conclusion the data show the ability of SAC to modify EAE evolution. Topics: Acute-Phase Proteins; Animals; Biomarkers; Carrier Proteins; Cysteine; Dose-Response Relationship, Drug; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Intestinal Mucosa; Intestines; Lipopolysaccharides; Male; Membrane Glycoproteins; Multiple Sclerosis; Oxidative Stress; Rats; Tumor Necrosis Factor-alpha | 2017 |